Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
20.01.26
/
50%
€54.00
Target price
20.01.27
€63.57
Performance (%)
0.41%
Price
16:16
€54.22
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc. is nearly unchanged. This prediction currently runs until 20.01.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -9.887% | -9.887% |
| iShares Core DAX® | -1,50 % | 7,70 % |
| iShares Nasdaq 100 | 1,38 % | 16,28 % |
| iShares Nikkei 225® | -1,99 % | 13,11 % |
| iShares S&P 500 | 0,35 % | 10,82 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at JPMorgan Chase & Co. from $70.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25